A phase II, randomized, double-blind, placebo-controlled, parallel group, dose-ranging study to investigate the efficacy and safety of 4 dose regimens of oral albaconazole in patients with distal subungual onychomycosis.
about
VT-1161 dosed once daily or once weekly exhibits potent efficacy in treatment of dermatophytosis in a guinea pig model.British Association of Dermatologists' guidelines for the management of onychomycosis 2014.New pharmacotherapy for the treatment of onychomycosis: an update.Novel investigational therapies for onychomycosis: an update.Azole antifungals: 35 years of invasive fungal infection management.Statistical reporting in randomized controlled trials from the dermatology literature: a review of 44 dermatology journals.Efinaconazole 10% topical solution for the topical treatment of onychomycosis of the toenail.Oral antifungal medication for toenail onychomycosis.Benzodiazines: recent synthetic advances.The antifungal pipeline: a reality check.A randomized, double-blind, multiple-dose, placebo-controlled, dose escalation study with a 3-cohort parallel group design to investigate the tolerability and pharmacokinetics of albaconazole in healthy subjects.How do we measure efficacy of therapy in onychomycosis: Patient, physician, and regulatory perspectives.Lewis Acid Catalyzed Condensation-Cyclization Cascade: Direct Synthesis of Di/Trifluoromethyl-1,2,3,4-tetrahydroquinazolines.Onychomycosis: A Review.
P2860
Q35168981-673F5299-E92F-4819-A629-0E1F846BB4B4Q35437556-BD4738BA-6E00-4E9D-AC37-3C1AF27E38E4Q35530025-FF9A6DDE-BA88-445F-BD82-AC518B17283BQ35893705-00E2FF04-915D-45BC-9B86-2912E53BE0B0Q38406393-0E8AD6CD-E422-41F1-BD40-18DFE5129502Q38491401-2CC0B1C0-A73B-4862-80ED-660C769814F4Q38577923-57C08CF9-B80D-4B64-A373-11554B216FE0Q38679387-E9D26E67-FB8A-4536-B1D4-F185EE4C1642Q39269222-C1B3CCDC-4BB6-4846-9871-FB51629F153FQ39299949-6C1D0693-01C9-408B-B587-04857DE1FB81Q39810673-A98D6CCF-5BD3-4DED-8AC0-95D8D130A53FQ39865044-C9C3A6D6-A7AB-4158-8BA1-2F58603A5E8AQ46072881-51F19A2B-E778-406E-98EB-2C2935CE6A0CQ48149284-359A0F7C-89DD-46AB-B060-9A60AA62189F
P2860
A phase II, randomized, double-blind, placebo-controlled, parallel group, dose-ranging study to investigate the efficacy and safety of 4 dose regimens of oral albaconazole in patients with distal subungual onychomycosis.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
A phase II, randomized, double ...... istal subungual onychomycosis.
@en
A phase II, randomized, double ...... istal subungual onychomycosis.
@nl
type
label
A phase II, randomized, double ...... istal subungual onychomycosis.
@en
A phase II, randomized, double ...... istal subungual onychomycosis.
@nl
prefLabel
A phase II, randomized, double ...... istal subungual onychomycosis.
@en
A phase II, randomized, double ...... istal subungual onychomycosis.
@nl
P2093
P1476
A phase II, randomized, double ...... distal subungual onychomycosis
@en
P2093
Kerry Raterink
Koen van Rossem
Steven Malahias
P304
P356
10.1016/J.JAAD.2013.03.021
P407
P577
2013-05-22T00:00:00Z